Your browser doesn't support javascript.
loading
A phase I dose-escalation study of danusertib (PHA-739358) administered as a 24-hour infusion with and without granulocyte colony-stimulating factor in a 14-day cycle in patients with advanced solid tumors.
Cohen, Roger B; Jones, Suzanne F; Aggarwal, Charu; von Mehren, Margaret; Cheng, Jonathan; Spigel, David R; Greco, F Anthony; Mariani, Mariangela; Rocchetti, Maurizio; Ceruti, Roberta; Comis, Silvia; Laffranchi, Bernard; Moll, Jurgen; Burris, Howard A.
Afiliação
  • Cohen RB; Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, USA. rb_cohen@fccc.edu
Clin Cancer Res ; 15(21): 6694-701, 2009 Nov 01.
Article em En | MEDLINE | ID: mdl-19825950

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Benzamidas / Proteínas Serina-Treonina Quinases / Antineoplásicos Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2009 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Benzamidas / Proteínas Serina-Treonina Quinases / Antineoplásicos Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2009 Tipo de documento: Article